About our content

Editorial policy

Last updated: 2026-07-22

GLP-1 medications are a health topic where accuracy matters and misinformation causes harm. These are the standards every guide and blog post on GLPMate is held to.

We never give dosing or medical advice

This is the line we do not cross. GLPMate is a tracking and education tool, not a clinician. Nothing we publish tells you what dose to take, when to change it, or what to do about a symptom. Those decisions belong with your prescriber and pharmacist, who know your history. Our content explains how these medicines are understood and what is worth tracking — and it points you back to your care team wherever a real decision is involved.

What we cite, and what we won't claim

Every clinical statement is sourced to primary references, in this order of preference:

  • FDA prescribing information (the drug labels) for dosing schedules, half-lives, titration intervals, missed-dose rules and documented adverse-event rates.
  • Peer-reviewed clinical trials — the STEP (semaglutide) and SURMOUNT (tirzepatide) programs in The New England Journal of Medicine, PIONEER for oral semaglutide, and comparable registration studies.
  • Guidance from regulators and professional bodies where a labeled answer doesn't exist.

We do not make outcome or weight-loss promises, and we never attribute a clinical result to using our app. Where we mention trial findings, we frame them as published data from a specific study population — not as a prediction for you. Every article lists its sources, and statistics are attributed inline to the source they came from.

How often we refresh

Health content goes stale. We run a 90-day refresh cadence: each guide and post is reviewed at least quarterly against the current FDA labels and literature, and the visible “Last updated” date on every page reflects the latest substantive review — it is not cosmetic. When a label changes or new evidence lands, we update the affected pages ahead of that schedule.

Named clinical review is being added

We are in the process of bringing on a named clinical reviewer — a registered dietitian, pharmacist or physician — to review and sign our medical content. Until that byline is in place, we keep clinical depth deliberately measured, lean hard on primary sources, and surface this policy and a visible update date on every page. When a reviewer is signed, their credentials and review dates will appear on the articles they review.

Corrections

If you spot something inaccurate or out of date, tell us at [email protected]. We correct errors promptly and update the page's “Last updated” date when we do.

This site is educational and is not medical advice, diagnosis or treatment. Always consult a qualified healthcare professional about your medication and your health.

Start your GLP-1 journey with a companion that listens.

Free to start. iOS & Android.

Coming soon onApp Store GET IT ONGoogle Play